Company news
Skinbiotherapeutics Plc (LSE:SBTX) news
Every Skinbiotherapeutics Plc press release and news update in one place — announcements, filings coverage, and company updates for investors.
Press releases & updates
Appointment of Interim CFO
August 24, 2026
IMC Presentation Statement
June 29, 2026
Notice of Investor Presentation
June 23, 2026
Restoration - SkinBioTherapeutics PLC
June 8, 2026
Update on Investigation, Interims and Auditors
May 28, 2026
Update on the FRP Investigation
April 29, 2026
Holding(s) in Company
April 1, 2026
Update On Board Investigation and Interims Date
March 20, 2026
Appointment of the Interim CEO to the Board
March 9, 2026
Appointment of Interim CEO
March 2, 2026
Independent Investigation Appointment
February 20, 2026
Update on Board Investigation
February 16, 2026
Resignation of CEO
February 13, 2026
Issue of Equity and Total Voting Rights
February 11, 2026
Total Voting Rights
January 22, 2026
Directorate change
January 5, 2026
Result of AGM
December 29, 2025
Reconfirmation of Market Guidance and AGM Q&A
December 18, 2025
Posting of Annual Report and AGM Notice
December 8, 2025
Final Results
December 5, 2025
Directorate Change
October 14, 2025
Superdrug first phase of store locations
October 6, 2025
FY Trading Update
August 14, 2025
Croda Commercial Launch Progressing as Expected
June 30, 2025
Notice of IMC Shareholder Presentation
June 27, 2025
Result of WRAP Retail Offer
June 20, 2025
WRAP Retail Offer
June 16, 2025
Correction: Change of Adviser
May 22, 2025
Board Appointment Confirmation
April 28, 2025
Board and Leadership Changes
April 24, 2025
Zenakine™ Technical Presentation & Share Price
April 9, 2025
Croda Launches Zenakine™ at in-cosmetics Global
April 8, 2025
Warrant Exercise Notice and Total Voting Rights
April 3, 2025
Half-year Report
March 26, 2025
Exercise of Warrants and Total Voting Rights
February 24, 2025
Posting of Annual Report and Notice of AGM
December 4, 2024
Notice of Results
November 29, 2024
Finalisation of commercial agreement with Croda
November 19, 2024
Integration update and share price movement
October 23, 2024
Acquisition and Financial Update
October 11, 2024
Notice of Investor Meet Company Presentation
October 4, 2024
Final testing of SkinBiotix by Croda completed
September 19, 2024
Investment of £1.56m from new investors
August 2, 2024
Appointment of Senior Croda VP as Board Advisor
July 29, 2024
Closure of Convertible Bond Facility
July 23, 2024
Conversion Notice and Total Voting Rights
July 22, 2024
Notice of Business Update & Investor Presentation
July 15, 2024
AxisBiotix Acne study reports positive data
June 18, 2024
Conversion Notice & Total Voting Rights
April 5, 2024
New research project and CSO to return to academia
March 18, 2024